(Q45020586)

8 December 2017

Aminopyridazines attenuate hippocampus-dependent behavioral deficits induced by human beta-amyloid in a murine model of neuroinflammation (English)

1 reference

8 December 2017

0 references

1 reference

5

1 reference

8 December 2017

Jeffrey M Craft

1

1 reference

8 December 2017

Linda J Van Eldik

series ordinal

2

1 reference

8 December 2017

Magdalena Zasadzki

series ordinal

3

1 reference

8 December 2017

Wenhui Hu

series ordinal

4

1 reference

8 December 2017

1 January 2004

1 reference

Journal of Molecular Neuroscience

8 December 2017

1 reference

8 December 2017

24

1 reference

8 December 2017

1

1 reference

8 December 2017

115-122

1 reference

https://scigraph.springernature.com/pub.10.1385/jmn:24:1:115

8 December 2017

0 references

cites work

Therapies directed at vascular endothelial growth factor

1 reference

12 December 2020

Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression

1 reference

12 December 2020

Aminopyridazines--an alternative route to potent muscarinic agonists with no cholinergic syndrome.

1 reference

12 December 2020

Rodent models of Alzheimer's disease: rat A beta infusion approaches to amyloid deposits

1 reference

12 December 2020

Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology

1 reference

12 December 2020

Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability.

1 reference

12 December 2020

Aminopyridazines inhibit beta-amyloid-induced glial activation and neuronal damage in vivo

1 reference

12 December 2020

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

1 reference

12 December 2020

An aminopyridazine-based inhibitor of a pro-apoptotic protein kinase attenuates hypoxia-ischemia induced acute brain injury

1 reference

12 December 2020

Multicentric double-blind study comparing efficacy and safety of minaprine and imipramine in dysthymic disorders

1 reference

12 December 2020

Inflammation and Alzheimer's disease

1 reference

12 December 2020

Clinically tested drugs for Alzheimer's disease

1 reference

12 December 2020

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE

1 reference

12 December 2020

Management of cognition and function: new results from the clinical trials programme of Aricept(R) (donepezil HCl).

1 reference

12 December 2020

Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial

1 reference

12 December 2020

Donepezil: a review of its use in Alzheimer's disease

1 reference

12 December 2020

Protein kinase involved in lung injury susceptibility: evidence from enzyme isoform genetic knockout and in vivo inhibitor treatment

1 reference

12 December 2020

Role of presenilin in gamma-secretase cleavage of amyloid precursor protein

1 reference

12 December 2020

Discovery of a new class of synthetic protein kinase inhibitors that suppress selective aspects of glial activation and protect against beta-amyloid induced injury: a foundation for future medicinal chemistry efforts focused on targeting Alzheimer's

1 reference

12 December 2020

Hepatotoxicity of thiazolidinediones

1 reference

12 December 2020

S100 beta expression in Alzheimer's disease: relation to neuropathology in brain regions.

1 reference

12 December 2020

Double-blind comparative study of the antidepressant, unwanted and cardiac effects of minaprine and amitriptyline

1 reference

12 December 2020

Drug-like properties and the causes of poor solubility and poor permeability

1 reference

12 December 2020

Discovery of a 3-amino-6-phenyl-pyridazine derivative as a new synthetic antineuroinflammatory compound

1 reference

12 December 2020

Identifiers

DOI

10.1385/JMN:24:1:115

1 reference

Dimensions Publication ID

8 December 2017

0 references

1 reference